Cargando…

Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396759/
https://www.ncbi.nlm.nih.gov/pubmed/37538083
http://dx.doi.org/10.1155/2023/9826918
_version_ 1785083833645793280
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10396759
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103967592023-08-03 Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway Markers, Disease Dis Markers Retraction Hindawi 2023-07-26 /pmc/articles/PMC10396759/ /pubmed/37538083 http://dx.doi.org/10.1155/2023/9826918 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title_full Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title_fullStr Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title_full_unstemmed Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title_short Retracted: Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway
title_sort retracted: rosiglitazone alleviates contrast-induced acute kidney injury in rats via the pparγ/nlrp3 signaling pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396759/
https://www.ncbi.nlm.nih.gov/pubmed/37538083
http://dx.doi.org/10.1155/2023/9826918
work_keys_str_mv AT markersdisease retractedrosiglitazonealleviatescontrastinducedacutekidneyinjuryinratsviatheppargnlrp3signalingpathway